# Firdapse

Type: Product

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/firdapse
Canonical HTML page: https://getbiobrief.com/entity/firdapse

## Recent coverage (1 stories)

### Catalyst Pharmaceuticals and Root Set for Pivotal Wednesday Earnings Reports
2026-02-24 09:47:16 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Catalyst Pharmaceuticals (CPRX) and Root (ROOT) are scheduled to release their quarterly financial results this Wednesday, February 25. For Catalyst, the report will be a critical barometer for the commercial uptake of its newly launched DMD treatment, Agamree, and the continued stability of its flagship LEMS therapy, Firdapse.
Full story: https://getbiobrief.com/story/catalyst-pharmaceuticals-root-earnings-preview-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.